SCHEMBL6712965

SCHEMBL6712965

CCOC(=O)C(Cc1ccc(OCCNC(=O)c2ccc(OCC(F)(F)C(F)F)nc2)cc1)Oc1ccc(C(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP2J2 P51589 1/20 0.41
TRPV1 Q8NER1 1/20 0.38
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37
NPC1 O15118 3/20 0.37
HCAR2 Q8TDS4 4/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
DGAT1 O75907 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6722406 0.92 EPHX2 (0.45) EPHX2CYP2C9CYP2C19CYP2J2TRPV1
SCHEMBL6718358 0.90 EPHX2 (0.42) EPHX2CYP2C9CYP2C19CYP2J2TRPV1
SCHEMBL6716079 0.86 EPHX2 (0.41) EPHX2CYP2C9CYP2C19CYP2J2TRPV1
SCHEMBL7229221 0.84 EPHX2 (0.42) EPHX2CYP2C9CYP2C19CYP2J2TRPV1
SCHEMBL6713371 0.82 EPHX2 (0.45) EPHX2CYP2C9CYP2C19CYP2J2TRPV1
SCHEMBL6716087 0.81 HCAR2 (0.48) EPHX2MMP9MMP12NPC1HCAR2
SCHEMBL6718747 0.81 GCG (0.48) TRPV1MMP9MMP12NPC1HCAR2
SCHEMBL6712975 0.80 GCG (0.47) EPHX2TRPV1NPC1HCAR2KMT2A
SCHEMBL6716025 0.80 GCG (0.47) EPHX2NPC1HCAR2PPARGPPARA
SCHEMBL6715149 0.79 NPC1 (0.46) NPC1PPARGPPARAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 EPHX2 3288/4885CYP2C9 1036/4885CYP2C19 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.